Clinical trials: Tricuspid Valve Disease

Tricuspid Regurgitation

Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER)

• Completed
• Age: 22 years and older
• Phase 3
• Medical device
• Results posted

The goal of this study is to determine the short term safety (<30 days) and efficacy (6 months) of the heterotopic implantation of the Edwards-Sapien XT valve in the inferior vena cava for the treatment of severe tricuspid…

Trial name

HOVER (NCT02339974)

Testing

Heterotopic Implantation Of the Edwards-Sapien XT Transcatheter Valve in the Inferior VEna Cava

Where

United States

Volunteers

15 people

Sponsor

Henry Ford Health System